The Safety of Use of Class IC Anti-Arrhythmic Drugs in Patients with Nonobstructive Coronary Artery Disease Present on Coronary CTA

Authors

Swapna Gudipati, Beaumont Health Fellow
Andrew Sherman, Beaumont Health Resident
Luai Madanat, Beaumont Health Fellow
Timothy J. Pow, Beaumont Health Fellow
Julie George, Beaumont Health
Abhisek J. Deshmukh
David E. Haines, Beaumont Health
Nishaki Mehta, Beaumont Health

Document Type

Conference Proceeding

Publication Date

5-2023

Publication Title

Heart Rhythm

Volume

20

Issue

5 Supp

First Page

S23

Comments

Abstract CE-452779-2, Heart Rhythm 2023 May 19-21, 2023, New Orleans LA.

Recommended Citation

Gudipati S, Sherman A, Madanat L, Pow TJ, George J, Deshmukh AJ et al. [Haines DE, Mehta N] The Safety of use of class IC anti-arrhytmic drugs in patients with nonobstructive coronary artery disease present on coronary CTA. Heart Rhythm 2023 May; 20(5 Supp):S23. doi:10.1016/j.hrthm.2023.03.245

DOI

10.1016/j.hrthm.2023.03.245